Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs3133446 | chr11:93196249 | C/A | 6.87E-5 | 108 | 6.13 | 12.17 | 16.3 | KM Plot |
LAML | rs33825 | chr19:33989245 | C/T | 1.27E-5 | 111 | 17.23 | 9.13 | 3 | KM Plot |
LAML | rs33827 | chr19:33986379 | G/A | 1.27E-5 | 110 | 17.23 | 10.67 | 3 | KM Plot |
LAML | rs33980254 | chr17:28592047 | C/T | 0.000116 | 111 | 19.82 | 15.7 | 6.1 | KM Plot |
LAML | rs34071565 | chr11:119712522 | A/T | 6.2E-5 | 109 | 15.2 | 10.67 | 0 | KM Plot |
LAML | rs34133266 | chr19:12549400 | TA/T | 1.87E-5 | 111 | 6.13 | 22.37 | 13.1 | KM Plot |
LAML | rs34159706 | chr10:1069190 | C/T | 1.64E-5 | 111 | 13.15 | 20.3 | 2.55 | KM Plot |
LAML | rs34180883 | chr14:77857190 | G/A | 0.000164 | 111 | 13.15 | 20.27 | 1.02 | KM Plot |
LAML | rs34181875 | chr1:43352494 | A/AG | 0.000186 | 109 | 15.23 | 10.67 | 1.02 | KM Plot |
LAML | rs34204050 | chr13:111023282 | T/G | 0.000126 | 111 | 13.2 | 19.33 | 0 | KM Plot |
LAML | rs34270668 | chr10:981685 | G/A | 6.36E-5 | 111 | 15.23 | 16.17 | 5.1 | KM Plot |
LAML | rs34362312 | chr10:956161 | TC/T | 4.43E-5 | 110 | 15.23 | 14.63 | 5.1 | KM Plot |
LAML | rs34368826 | chr3:48670827 | G/T | 0.000106 | 111 | 15.73 | 11.68 | 0 | KM Plot |
LAML | rs34461118 | chr19:12558588 | T/A | 1.56E-5 | 110 | 6.63 | 21.27 | 13.1 | KM Plot |
LAML | rs34622227 | chr17:28629819 | T/G | 0.000116 | 111 | 19.82 | 15.7 | 6.1 | KM Plot |